ReNerve Limited (ASX:RNV)
Australia · Delayed Price · Currency is AUD 0.0870
0.00 (0.00%)
Oct 7, 2026, 11:44 AM AEST
ReNerve Market Cap
ReNerve has a market cap or net worth of 14.99 million as of October 9, 2026. It is the 41,418th most valuable company in the world and the 1,207th biggest in Australia. Its market cap has decreased by 25.58% in one year.
Market Cap
14.99M
Enterprise Value
13.70M
Revenue
510.36K
Global Rank
Country Rank
#1,207 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since November 26, 2024, ReNerve's market cap has decreased from 26.95M to 14.99M, a decrease of -44.38%. That is a compound annual growth rate of -27.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 14.99M | -9.40% |
| Dec 31, 2025 | 16.55M | -33.34% |
| Dec 31, 2024 | 24.82M | -7.89% |
| Nov 26, 2024 | 26.95M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Imugene | 20.08M |
| Proteomics International Laboratories | 19.84M |
| Noxopharm | 19.05M |
| Algorae Pharmaceuticals | 18.25M |
| Ceryvyn Therapeutics | 17.78M |
| Patrys | 17.47M |
| Argenica Therapeutics | 16.70M |
| EZZ Life Science Holdings | 16.47M |